Skip to main content
Premium Trial:

Request an Annual Quote

NSF To Award $5.6M to Businesses Developing Bioinformatics, Other Tools for Bioeconomy

Premium

The National Science Foundation has issued a call for Phase I proposals for a Small Business Technology Transfer program to support private-sector projects that enhance the bioeconomy using emerging biological technologies.

According to the solicitation letter, submitted proposals must use a biologically based approach, such as synthetic biology, systems biology, metabolic engineering, proteomics, bioinformatics, and computational biology, to address business opportunities in key industry sectors including biomedical, biomanufacturing, and sustainable agriculture.

Pending funding availability, NSF intends to provide $5,625,000 under the program, which will be used to fund 25 projects.

Interested researchers must submit letters of intent between Oct. 20 and Nov. 20 and full proposals must be submitted by Dec. 20.

Proposals should include, among other details, a project summary, description, references cited, biographical sketches, budgets and subbudgets, as well as supplementary documents.

Filed under

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.